Stock Comparison
TAK vs UTHR
Takeda Pharmaceutical Co Ltd ADR and United Therapeutics Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$50.27B
$23.03B
P/E (TTM)
—
20.1
Forward P/E
10.3
19.8
Price/Sales
0.0
7.3
Price/Book
1.1
3.9
EV/EBITDA
16.9
11.6
Dividend Yield
4.16%
—
Profitability
Net Margin
-3.38%
40.60%
Operating Margin
11.10%
41.70%
Return on Equity
-2.12%
20.30%
Return on Assets
2.55%
12.60%
Growth (YoY)
Revenue Growth
3.90%
-1.60%
Earnings Growth
330.20%
-12.20%
Price & Risk
Beta
0.1
0.6
52-Week High
$18.90
$609.35
52-Week Low
$12.78
$272.12
Analyst Target
$20.60
$665.23
Compare TAK and UTHR your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.